Published on March 17, 2009
Contact: Linda Caradine
Phone: 1-800-323-4040, ext. 7461
See the Future—Today
Pathology Leaders Convene to Discuss the Future of the Profession at the College of American Pathologists Foundation Futurescape Conference on June 12-14, 2009
Northfield, IL.—“Transforming Pathology: Information as a Disruptive Technology” is the theme of the College of American Pathologists Foundation third annual Futurescape Conference taking place June 12-14, 2009, at the Westin O’Hare in Rosemont, Ill. Pathologists, medical laboratory professionals, and industry and business leaders related to the specialty will gather to discuss how to meet the future challenges in an ever-changing technological environment.
This year’s theme, “Transforming Pathology: Emerging Technology Driving Practice Innovation,” examines biomarkers, their correct interpretation, and the integration of data from disparate information systems. During the conference, experts will discuss the role of personalized medicine in getting the right treatment to the right patient at the right time.
“The CAP Foundation designed this year’s conference to foster a ‘two-way’ conversation between the decision-makers from pathology, business, technology and the financial industries,” said Mary E. Kass, MD, FCAP, president of the CAP Foundation. “Attendees will have the opportunity to hear from industry leaders, corporate researchers, and venture capitalists’ on what they believe is the most promising technology for the future of pathology, as well as share their ideas and provide input about the evolution of profession.”
The conference will begin with a keynote address from co-presenters Mara Aspinall, Senior Advisor, Genzyme Corporation and Jason Hwang, MBA, MD, co-author of the book, The Innovator’s Prescription: A Disruptive Solution to the Health Care Crisis, which will set the stage with other leading pathologists, medical professionals, and industry leaders. In addition, attendees will learn about:
- Key components to provide better diagnosis and therapy decisions for improved patient care
- Innovative and driving forces of change in personalized medicine, the role of biomarkers in diagnosis and therapy
- More effective methods for communicating with clinical partners and patients
“We are thrilled about the line-up of speakers, as well as topics that will be addressed at this year’s conference,” said Dr. Kass. “Our hope is that the attendees will have the opportunity to reflect on the future of pathology during the Foundation’s Futurescape Conference and feel more prepared to embrace the changes that lie ahead.”
The College of American Pathologists (CAP) Foundation, a 501(c)3 association, is the leading philanthropic organization for pathologists. Through the generous support of the CAP of the Foundation’s administrative needs, 100 percent of all contributes are distributed to fund educational, research, and humanitarian programs related to pathology.